)
Edge15 May 2026
TOMRA: Closing the Loop
The story of TOMRA: from reverse vending machine pioneer to global technology for deposit systems, recycling, and resource optimization.
Consun Pharmaceutical Group
Consun Pharmaceutical Group (1681) investor relations material
Consun Pharmaceutical Group H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary26 Mar, 2026
Executive summary
Revenue for 2025 reached RMB3.42 billion, up 15.2% year-over-year, with profit attributable to equity shareholders rising 18.4% to RMB1.08 billion.
Gross profit margin improved to 78.0% from 75.6% due to production efficiency and supplier optimization.
Core product lines, especially kidney medicines, drove growth, with kidney medicines sales up 20.3% and medical contrast medium up 10.9%.
R&D and digitalization were emphasized, with new drug approvals and international clinical trials initiated.
The company maintained a strong liquidity position and continued to invest in innovation and operational efficiency.
Financial highlights
Revenue: RMB3,417,355,000 (+15.2% YoY); Gross profit: RMB2,667,120,000 (+19.0% YoY).
Profit attributable to equity shareholders: RMB1,078,067,000 (+18.4% YoY).
Basic EPS: RMB1.27 (+14.4% YoY); Diluted EPS: RMB1.26 (+15.6% YoY).
Gross profit margin: 78.0% (+2.4pp YoY); Effective tax rate: 9.0% (down 1.1pp YoY).
Final dividend proposed: HKD0.40 per share; total dividend for the year: HKD0.73 per share (>50% payout ratio).
Outlook and guidance
Focus on high-quality growth through organizational reform, digital transformation, and scientific marketing.
Continued investment in R&D, digitalization, and operational efficiency to drive sustainable growth.
Anticipates further normalization of medical insurance cost control and targeted centralized procurement in 2026.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Consun Pharmaceutical Group
- Revenue up 23.7% and net profit up 24.6% year-over-year; interim dividend declared.1681
H1 202512 May 2026 - Revenue and profit grew double digits, with a higher interim dividend and robust segment growth.1681H1 202412 May 2026
- Revenue and profit rose over 14%, with strong core product growth and high dividend payout.1681H2 202412 May 2026
Next Consun Pharmaceutical Group earnings date
H1 202618 Aug, 2026
Consun Pharmaceutical Group
Next Consun Pharmaceutical Group earnings date
H1 202618 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage